Huntington's disease (HD) is a severe autosomal-dominant neurodegenerative disorder caused by a mutation within a gene, encoding huntingtin protein. Here we have used the induced pluripotent stem cell technology to produce patient-specific terminally differentiated GABA-ergic medium spiny neurons modeling a juvenile form of HD (HD76). We have shown that calcium signaling is dramatically disturbed in HD76 neurons, specifically demonstrating higher levels of store-operated and voltage-gated calcium uptakes. However, comparing the HD76 neurons with the previously described low-repeat HD models, we have demonstrated that the severity of calcium signaling alterations does not depend on the length of the polyglutamine tract of the mutant huntingtin. Here we have also observed greater expression of huntingtin and an activator of store-operated calcium channels STIM2 in HD76 neurons. Since shRNA-mediated suppression of STIM2 decreased store-operated calcium uptake, we have speculated that high expression of STIM2 underlies the excessive entry through store-operated calcium channels in HD pathology. Moreover, a previously described potential anti-HD drug EVP4593 has been found to attenuate high levels of both huntingtin and STIM2 that may contribute to its neuroprotective effect. Our results are fully supportive in favor of the crucial role of calcium signaling deregulation in the HD pathogenesis and indicate that the cornerstone of excessive calcium uptake in HD-specific neurons is a calcium sensor and store-operated calcium channels activator STIM2, which should become a molecular target for medical treatment and novel neuroprotective drug development.
Induced pluripotent stem cells (iPSCs) have the capacity to unlimitedly
proliferate and differentiate into all types of somatic cells. This capacity
makes them a valuable source of cells for research and clinical use. However,
the type of cells to be reprogrammed, the selection of clones, and the various
genetic manipulations during reprogramming may have an impact both on the
properties of iPSCs and their differentiated derivatives. To assess this
influence, we used isogenic lines of iPSCs obtained by reprogramming of three
types of somatic cells differentiated from human embryonic stem cells. We
showed that technical manipulations in vitro, such as cell
sorting and selection of clones, did not lead to the bottleneck effect, and
that isogenic iPSCs derived from different types of somatic cells did not
differ in their ability to differentiate into the hematopoietic and neural
directions. Thus, the type of somatic cells used for the generation of fully
reprogrammed iPSCs is not important for the practical and scientific
application of iPSCs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.